vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and OXFORD INDUSTRIES INC (OXM). Click either name above to swap in a different company.
OXFORD INDUSTRIES INC is the larger business by last-quarter revenue ($307.3M vs $196.0M, roughly 1.6× Axsome Therapeutics, Inc.). Axsome Therapeutics, Inc. runs the higher net margin — -14.6% vs -20.7%, a 6.1% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -0.2%). Axsome Therapeutics, Inc. produced more free cash flow last quarter ($-18.7M vs $-47.9M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -3.0%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Oxford Industries, Inc. is a publicly traded clothing company in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Johnny Was and Southern Tide.
AXSM vs OXM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $307.3M |
| Net Profit | $-28.6M | $-63.7M |
| Gross Margin | — | 60.3% |
| Operating Margin | -13.8% | -27.7% |
| Net Margin | -14.6% | -20.7% |
| Revenue YoY | 65.0% | -0.2% |
| Net Profit YoY | 61.9% | -1517.6% |
| EPS (diluted) | $-0.55 | $-4.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $307.3M | ||
| Q3 25 | $171.0M | $403.1M | ||
| Q2 25 | $150.0M | $392.9M | ||
| Q1 25 | $121.5M | — | ||
| Q4 24 | $118.8M | $308.0M | ||
| Q3 24 | $104.8M | $419.9M | ||
| Q2 24 | $87.2M | $398.2M | ||
| Q1 24 | $75.0M | $404.4M |
| Q4 25 | $-28.6M | $-63.7M | ||
| Q3 25 | $-47.2M | $16.7M | ||
| Q2 25 | $-48.0M | $26.2M | ||
| Q1 25 | $-59.4M | — | ||
| Q4 24 | $-74.9M | $-3.9M | ||
| Q3 24 | $-64.6M | $40.6M | ||
| Q2 24 | $-79.3M | $38.4M | ||
| Q1 24 | $-68.4M | $-60.1M |
| Q4 25 | — | 60.3% | ||
| Q3 25 | — | 61.4% | ||
| Q2 25 | — | 64.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 63.1% | ||
| Q3 24 | — | 63.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 60.9% |
| Q4 25 | -13.8% | -27.7% | ||
| Q3 25 | -27.0% | 6.3% | ||
| Q2 25 | -24.5% | 9.2% | ||
| Q1 25 | -46.9% | — | ||
| Q4 24 | -61.1% | -2.0% | ||
| Q3 24 | -59.8% | 12.5% | ||
| Q2 24 | -89.5% | 13.2% | ||
| Q1 24 | -89.7% | -20.1% |
| Q4 25 | -14.6% | -20.7% | ||
| Q3 25 | -27.6% | 4.1% | ||
| Q2 25 | -32.0% | 6.7% | ||
| Q1 25 | -48.9% | — | ||
| Q4 24 | -63.1% | -1.3% | ||
| Q3 24 | -61.7% | 9.7% | ||
| Q2 24 | -91.0% | 9.6% | ||
| Q1 24 | -91.1% | -14.9% |
| Q4 25 | $-0.55 | $-4.28 | ||
| Q3 25 | $-0.94 | $1.12 | ||
| Q2 25 | $-0.97 | $1.70 | ||
| Q1 25 | $-1.22 | — | ||
| Q4 24 | $-1.54 | $-0.25 | ||
| Q3 24 | $-1.34 | $2.57 | ||
| Q2 24 | $-1.67 | $2.42 | ||
| Q1 24 | $-1.44 | $-3.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $8.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $528.0M |
| Total Assets | $689.8M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $8.0M | ||
| Q3 25 | $325.3M | $6.9M | ||
| Q2 25 | $303.0M | $8.2M | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | $7.0M | ||
| Q3 24 | $327.3M | $18.4M | ||
| Q2 24 | $315.7M | $7.7M | ||
| Q1 24 | $331.4M | $7.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $29.0M |
| Q4 25 | $88.3M | $528.0M | ||
| Q3 25 | $73.7M | $597.1M | ||
| Q2 25 | $73.1M | $592.4M | ||
| Q1 25 | $53.2M | — | ||
| Q4 24 | $57.0M | $612.2M | ||
| Q3 24 | $92.9M | $621.6M | ||
| Q2 24 | $102.9M | $592.9M | ||
| Q1 24 | $144.0M | $560.9M |
| Q4 25 | $689.8M | $1.3B | ||
| Q3 25 | $669.3M | $1.3B | ||
| Q2 25 | $639.8M | $1.3B | ||
| Q1 25 | $596.7M | — | ||
| Q4 24 | $568.5M | $1.2B | ||
| Q3 24 | $561.5M | $1.2B | ||
| Q2 24 | $548.2M | $1.2B | ||
| Q1 24 | $545.7M | $1.1B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $-9.1M |
| Free Cash FlowOCF − Capex | $-18.7M | $-47.9M |
| FCF MarginFCF / Revenue | -9.6% | -15.6% |
| Capex IntensityCapex / Revenue | 0.0% | 12.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-79.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $-9.1M | ||
| Q3 25 | $1.0M | $83.5M | ||
| Q2 25 | $-32.4M | $-3.9M | ||
| Q1 25 | $-43.4M | — | ||
| Q4 24 | $-26.2M | $-18.2M | ||
| Q3 24 | $-18.6M | $88.8M | ||
| Q2 24 | $-30.1M | $32.9M | ||
| Q1 24 | $-53.5M | $74.9M |
| Q4 25 | $-18.7M | $-47.9M | ||
| Q3 25 | $988.0K | $52.3M | ||
| Q2 25 | $-32.4M | $-27.4M | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | $-56.9M | ||
| Q3 24 | $-18.7M | $47.2M | ||
| Q2 24 | $-30.2M | $21.0M | ||
| Q1 24 | $-53.6M | $55.3M |
| Q4 25 | -9.6% | -15.6% | ||
| Q3 25 | 0.6% | 13.0% | ||
| Q2 25 | -21.6% | -7.0% | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | -18.5% | ||
| Q3 24 | -17.9% | 11.2% | ||
| Q2 24 | -34.6% | 5.3% | ||
| Q1 24 | -71.4% | 13.7% |
| Q4 25 | 0.0% | 12.6% | ||
| Q3 25 | 0.0% | 7.7% | ||
| Q2 25 | 0.0% | 6.0% | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | 12.6% | ||
| Q3 24 | 0.1% | 9.9% | ||
| Q2 24 | 0.1% | 3.0% | ||
| Q1 24 | 0.1% | 4.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.00× | ||
| Q2 25 | — | -0.15× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.19× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
